Brain imaging study for early Parkinson's signs in people with REM sleep disorder
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study uses MRI scans to look at the brain in people with REM sleep behavior disorder (RBD), a condition that can be an early sign of Parkinson's disease. By comparing them with healthy volunteers, researchers hope to find early markers of Parkinson's that could lead to earlier diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give informed consent.
- For the RBD group: You need a confirmed diagnosis of REM sleep behavior disorder (RBD) via a sleep study.
- For the healthy control group: You must be age-matched to the RBD group and have no significant neurological or psychiatric illness.
- You must not have any ferrous (metal) objects in or on your body, or a pacemaker or other implanted electronic device.
- You must not have claustrophobia (fear of enclosed spaces) and must be able to lie still in an MRI scanner.
- You must not have a history of drug or alcohol abuse (unrelated to medication) in the last 6 months, and no participation in drug-testing trials in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines brain changes in people with REM sleep behavior disorder (acting out dreams during sleep) and early Parkinson's disease using brain imaging scans. Researchers want to understand how sleep problems relate to Parkinson's development and find early warning signs.
This study looks at people with REM sleep behavior disorder (RBD), confirmed by a sleep test, who may be in the early “prodromal” stage before Parkinson’s or related diseases. It also enrolls healthy controls to compare results from brain and body testing to better understand who is at risk.
This study enrolls people with idiopathic REM sleep behavior disorder, a sleep problem that can come before Parkinson’s disease or related conditions. It aims to better understand early (“prodromal”) changes so future treatments can be targeted earlier.
This study collects blood and related samples to create a “biobank” and uses lab tests to study genetic risk in Parkinson’s disease and idiopathic REM sleep behavior disorder (RBD). It may help researchers understand why symptoms develop and improve future prevention or treatment approaches.
This study looks at how the brain changes (“neuroplasticity”) in people diagnosed with isolated REM sleep behavior disorder (iRBD) using brain stimulation and other testing. Results may help researchers understand brain differences in iRBD and guide future treatments.
This study uses artificial intelligence to analyze brain scans and predict whether people with REM sleep behavior disorder are at risk of developing Parkinson's disease. It aims to find early signs before symptoms appear.
Hear when a new REM Sleep Behavior Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.